By removing the psychological and practical barriers associated with injectable treatments, oral GLP-1s have the potential to reposition obesity care as a routine, chronic intervention rather than a specialist-led, escalation therapy
J Biol Chem 277:3288332891 Tanizawa Y, Nakai K, Sasaki T et al (2002) Unregulated elevation of glutamate dehydrogenase activity induces glutamine-stimulated insulin secretion: identification and characterization of a GLUD1 gene mutation and insulin secretion studies with MIN6 cells overexpressing the mutant glutamate dehydrogenase
[Accessed 16th April 2026]
Some people notice mild appetite changes
Pregnant and breastfeeding women should avoid these therapies unless recommended by their physician
M., Valdiviezo, C., & Bao, W